# Follow up questions from Thursday's Webinar | EndoSound, Inc

- Canonical URL: https://wefunder.com/feed/397185
- Entity ID: wefunder:feed_item:397185
- Published at: 2026-09-29 14:33:07 UTC
- Updated at: 2026-09-29 15:39:24 UTC

## Author
Patrick Hurley

## Subject
EndoSound

## Content
Thank you to everyone who joined last Thursday's webinar. Below are questions from you and answers from Stephen Steinberg, MD, Interim CEO, which we did not have time to address live. The recording will be available later this week for your review. Please post any follow-up questions in the comments.1. What diseases and problems is EUS particularly useful for?Endoscopic ultrasound (EUS) is useful across a broad range of gastrointestinal problems, from abdominal pain to diseases of the liver, gallbladder, bile ducts, and many others. One of its most important roles is in pancreatic disease, particularly pancreatic cancer.EUS is one of the best modalities for imaging the pancreas because it combines exceptionally detailed, real-time imaging with the ability to obtain tissue and even target therapy. We can find and precisely locate a tumor, determine its extent, obtain tissue for diagnosis and molecular analysis, and help stage the cancer. EUS is also increasingly important in screening people at high risk for pancreatic cancer, where earlier detection can make an enormous difference.This is becoming even more important as pancreatic cancer treatments improve. The FDA recently approved the targeted therapy daraxonrasib, while HistoSonics, backed by Jeff Bezos, is studying an ultrasound-based treatment for pancreatic cancer. These advances require accurate diagnosis, localization, and staging. At the same time, increasingly personalized cancer treatment depends on understanding the molecular characteristics of an individual tumor—and in pancreatic cancer; that tissue is usually obtained by EUS-guided biopsy.So, as pancreatic cancer becomes more treatable and more personalized, EUS becomes even more important.That is where the EndoSound opportunity becomes particularly compelling. Advances in detection and treatment will drive greater need for EUS, and EVS removes many of the cost, access, and infrastructure barriers that have historically limited its availability. Our opportunity is not simply to compete for today’s EUS procedures—but rather to grow the market, to make EUS available to many more patients, in many more places.2. What is the opportunity for EndoSound outside the United States?We believe the international opportunity could be as significant as the U.S. opportunity.EUS is an critical technology, but legacy systems are expensive and require substantial infrastructure. In many parts of the world, that has limited access—not because the clinical need isn't there, but because the technology has simply been too expensive to deploy broadly.That creates a significant opportunity for EndoSound. In many of these countries, the patients, physicians, gastroscopes, and endoscopy infrastructure are already there. EVS provides a much less expensive, portable way to add EUS capability to that existing infrastructure.India is particularly exciting, with approximately 1.46 billion people and a rapidly growing healthcare and endoscopy market. We also see significant opportunities across Southeast Asia and in major endoscopy markets such as Japan and South Korea.There is also something about this opportunity that is personally important to me. EUS is an important medical technology, and where a patient lives or what their healthcare system can afford shouldn't determine whether they have access to it. EndoSound has the potential make EUS available to physicians and patients who previously couldn't access it-- the opportunity to build a very large global business while doing something genuinely important for healthcare.3. Is there a role for AI in EndoSound’s future?Absolutely. We believe AI can become an important part of the EndoSound platform, particularly as EUS expands beyond traditional expert centers.AI has potential value throughout the physician's experience with EUS: helping physicians learn the examination, objectively demonstrating competence, and supporting them during ongoing clinical use. During an examination, AI could help identify anatomy, confirm that important structures have been adequately examined, recognize abnormalities, and potentially improve outcomes by helping identify subtle findings such as small pancreatic cancers that might otherwise be missed.This could be particularly important for Echo-EGD and broader diagnostic EUS, where reducing the learning curve and making examinations more standardized and reproducible could substantially expand the number of physicians able to perform high-quality EUS.Importantly, these are not simply theoretical concepts. We already have collaborators working with us in each of these areas—training, competency assessment, and AI-assisted clinical performance.We don't need AI for EVS to succeed today, but it could significantly amplify what EVS makes possible tomorrow. EVS can make EUS more affordable and accessible; AI can help make it easier to learn, demonstrate proficiency, and perform consistently at a high level.Thank you again for your interest in EndoSound and for taking the time to join us. I hope these answers provide a little more perspective on both the clinical importance of EUS and the opportunity we see ahead.Please feel free to reach out to me directly with any additional questions. I’m always happy to talk about what we’re building and where we believe EndoSound can go.Cheers,Steve